Cardiovascular Outcomes in Orthotopic Liver Transplanted Patients (COLT Study)

NCT ID: NCT05895669

Last Updated: 2023-06-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-05-02

Study Completion Date

2024-05-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

All patients with orthotopic liver transplantation who are evaluated and followed at each participating centers will be recorded in this study. Within this register a characterization of patients and therapy will be done. Prognostic factors of defined clinical relevant endpoints will be evaluated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Liver Transplant; Complications Cardiovascular Complication Cardiovascular; Attack Cardiovascular Stroke Death

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients with ortothopic liver transplantation and at least 2 year follow-up at the referral center

Exclusion Criteria

* Missing Informed Consent Form
* Missing Contact Informations for Follow up
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Campania Luigi Vanvitelli

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alfredo Caturano

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gragnano Hospital

Gragnano, SA, Italy

Site Status RECRUITING

University of Campania Luigi Vanvitelli

Napoli, , Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Alfredo Caturano, MD

Role: CONTACT

+393338616985

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Carmine Coppola, MD

Role: primary

Alfredo Caturano, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0012771/i

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CTO-PCI in Heart Failure Patients
NCT05632653 NOT_YET_RECRUITING NA
Cardiovascular Metabolic Remodeling in Shock
NCT06285513 NOT_YET_RECRUITING